Navigation Links
New Data Presented at ACAAI Informs on the Safety and Efficacy of Nasacort AQ Nasal Spray in a Trial of Children Aged 2-5 Years Old with Year-Round Allergic Rhinitis
Date:11/10/2007

ate in the study, patients had to have year-round allergic rhinitis for at least one year and reported sufficiently severe symptoms of nasal stuffiness, discharge and sneezing. Also, all patients had to demonstrate sensitivity to such allergens in their system as shown by a positive skin prick test.

Every morning, caregivers were asked to rate his/her child's symptoms of sneezing, nasal stuffiness, discharge, and itching over the last 24 hours (reflective). Patients' symptoms were also rated at the time immediately before receiving their daily medication (instantaneous).

Over four weeks, patients treated with Nasacort AQ showed a statistically significant (P=0.0328) reduction in the combined symptoms of sneezing, nasal stuffiness, discharge and itching (Total Symptom Score or TSS) measured over the last 24 (-2.31 plus or minus 0.15) compared to placebo (-1.87 plus or minus .151). Immediately before receiving the daily treatment, patients treated with Nasacort AQ also reported a numeric, albeit not statistically significant (P= 0.0946), reduction (-2.28 plus or minus 0.16) in TSS compared to placebo (-1.92 plus or minus .16).

Side effects among patients treated with Nasacort AQ were similar to those given placebo and no serious adverse events or clinically meaningful changes in vital signs were reported in either group. Side effects associated with treatment occurred in 50.8% of patients receiving Nasacort AQ and 48.3% of subjects receiving placebo. The most common treatment-related adverse events during the 4-week of treatment with Nasacort AQ and placebo respectively were cough (7.6%, 9.2%), pyrexia (fever) (6.8%, 8%), headache (5.5%, 4.2%), and nasopharyngitis (nose & throat irritation) (5.1%, 3.8%).

In a subset of the same clinical study, Nasacort AQ showed no significant effect on average adrenal function in children aged 2-5 years with year-round allergic rhinitis

Also presented at ACAAI is a report on the effect of Nasacort AQ on
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. Success of Shape Up Somerville childhood obesity intervention to be presented
5. Survival data presented from phase II study of hormone-resistant prostate cancer patients
6. Special Olympics Special Spirit in China Award Of Excellence Presented to Dedicated Friends of Special Olympics and City of Shanghai
7. UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting
8. New Analyses of long-term LIALDA (mesalamine) data presented at ACG
9. Horizons AMI trial data to be presented at TCT 2007
10. AMIHOT II trial data presented at TCT
11. Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... new neurons in the hippocampus - a brain region ... could cause forgetting of old memories by causing a ... and Sheena Josselyn, both from the Hospital for Sick ... positive effect of clearing old memories, reducing interference and ... were presented at the 2013 Canadian Neuroscience Meeting, the ...
(Date:5/24/2013)... New York, NY (PRWEB) May 24, 2013 ... has granted Cellular Dynamics International (CDI) exclusive license rights ... cell therapy and regenerative medicine applications. These cells are ... of the heart, including cardiomyocytes, endothelial cells, and vascular ... a potential therapeutic for damaged heart tissue. , The ...
(Date:5/24/2013)... On May 16, students, family members, and ... American University of Antigua (AUA) College of Medicine ... was the largest graduating class to date. The ceremony ... Vice President for Enrollment Management and Chief Operating Officer, ... Dean of Students and Professor and Chair – Physiology, ...
(Date:5/24/2013)... 2013 The creative flair and design ... University (PolyU)'s Institute of Textiles and Clothing (ITC) have ... Fashion Show held on 22 May at The Mira ... of ITC design students, various knitwear producers and yarn ... collections of four outfits from 20 graduating students majoring ...
(Date:5/24/2013)... THURSDAY, May 23 (HealthDay News) -- Type 2 diabetes ... of serious complications seen just a few years after ... latest results, it seems like type 2 is progressing ... vice president of medical affairs and community information for ... it appears to be at a more significant rate ...
Breaking Medicine News(10 mins):Health News:New neuron formation could increase capacity for new learning, at the expense of old memories 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:AUA Celebrates Seventh Annual Commencement Ceremony 2Health News:PolyU Stages Knitwear Fashion Show 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 2Health News:Type 2 Diabetes Progresses Faster in Kids, Study Finds 3
... Tragedy: The mass shooting in Tucson that ... Congresswoman Gabrielle Giffords, brought significant attention to ... mental, emotional and behavioral disorders (MEBs) and substance abuse. ... be answered by a panel of experts, including Ron ...
... promising cancer treatment drug can restore function of a heart ... UT Southwestern Medical Center have found. The drug, a ... ongoing clinical trials, has been shown to reverse the harmful ... is a natural process by which cells eat their own ...
... enzyme associated with extensive antibiotic resistance called New Delhi ... worldwide, has been found in two people in the ... states a case report in CMAJ ( ... http://www.cmaj.ca/embargo/cmaj110477.pdf . The report outlines challenges and approaches to ...
... May 29 (HealthDay News) -- Attacks by North American black ... rising as the human population of the United States and ... in the Journal of Wildlife Management , also dispels ... mothers with cubs to protect. Researchers reveal that lone male ...
... -- Native American children in the United States and Canada ... other kids, according to a new policy statement from a ... oral health of those patients. A survey of 2,633 ... the United States, Alaska and Canada found that 68 percent ...
... symptoms is distressing for both patient and doctor and ... five patients have symptoms that remain unexplained by conventional ... NHS of managing the treatment of a patient with ... patient with a diagnosis. A research team ...
Cached Medicine News:Health News:Tucson tragedy; college athletes and drinking; depression in adolescents; and yoga and drug use 2Health News:Drug can reverse overgrown hearts to help prevent heart failure, UT Southwestern researchers find 2Health News:New Delhi metallo-beta-lactamase-1 enzyme acquired in Canada 2Health News:Fatal Black Bear Attacks Rare But Rising 2Health News:Native American Children Have More Tooth Decay 2Health News:Acupuncture of benefit to those with unexplained symptoms 2Health News:Acupuncture of benefit to those with unexplained symptoms 3
(Date:5/24/2013)... -- An international roster of experts on malignant pleural mesothelioma ... Santa Monica, Calif. , to discuss their latest ... rare form of cancer that results from exposure to ... the chest. Hosted by UCLA and the ... International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma ...
(Date:5/24/2013)... Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider ... Robert Grieve , the Company,s chairman and ... executive vice president and chief financial officer, will present at ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 1:30 p.m. EDT. ...
(Date:5/24/2013)... BEIJING , May 24, 2013 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company has recently learned from a public announcement issued ... a public company listed on Shenzhen Stock Exchange, that ... Chan ("Ms. Chan"), one of the shareholders ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
... Tongjitang Chinese Medicines Company (the "Company" or "Tongjitang") (NYSE: ... focusing on the development, manufacturing, marketing and selling of ... it plans to release its fourth quarter and full ... March 25, 2011. Tongjitang,s management team will ...
... MADISON, N.J., March 21, 2011 Quest Diagnostics ... provider of diagnostic testing, information and services, announced ... aggregate principal amount of four series of senior ... shelf registration statement filed with the Securities and ...
Cached Medicine Technology:Tongjitang Chinese Medicines Company to Announce Fourth Quarter and Full Year 2010 Financial Results 2Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering 2
... early 1990s, the "Reversed" shoulder prosthesis has ... great success. More recently, an ever-growing number ... begun to champion this prosthesis and the ... This reversed technology is the result of ...
... spectrofluorometer is the ... among the FLUORAT®-02 ... intended for scientific ... and for operation ...
... The Gemini XPS spectrofluorometer ... measurements as required by ... assays. Cellular and molecular ... drug screening, and SNP ...
The FluoroMax-3 is the entry level spectrofluorometer from Spex®, yet offers features not found in most of the top models of the competition....
Medicine Products: